Skip to main content

Table 3 Differences between the groups regarding the participation in the therapy and the experienced side effects

From: Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany

  NM FGM SGM/TGM p-value
Therapy
 Surgery 406 (92.5%) 94 (92.2%) 55 (91.7%) 0.97
 Chemotherapy 368 (84.2%) 87 (82.9%) 51 (85.0%) 0.27
 Radiotherapy 130 (30.9%) 33 (33.7%) 15 (25.4%) 0.74
 Anti-hormone therapy 98 (23.4%) 27 (26.7%) 17 (29.3%) 0.64
 Immunotherapy 171 (40.0%) 28 (29.2%) 25 (41.7%) 0.21
 Recurrence 164 (40.3%) 34 (35.1%) 29 (50.0%) 0.24
Therapy side effects
 Pain 198 (46.8%) 54 (52.9%) 26 (44.8%) 0.48
 Alopecia 288 (68.1%) 72 (70.6%) 42 (72.4%) 0.74
 Fatigue 253 (59.8%) 67 (65.7%) 41 (70.7%) 0.19
 Blood changes 220 (52.0%) 42 (41.2%) 34 (58.6%) 0.06
 Cardiac function changes 16 (3.8%) 9 (8.8%) 1 (1.7%) 0.05
 Nausea 158 (37.4%) 50 (49.0%) 31 (53.4%) 0.01
 Paresthesia 240 (56.7%) 56 (54.9%) 36 (62.1%) 0.67